Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Abemaciclib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abemaciclib 100mg tablets
0801050CLAAAAAA
|
Abemaciclib | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
|
Abemaciclib 150mg tablets
0801050CLAAABAB
|
Abemaciclib | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
|
Abemaciclib 50mg tablets
0801050CLAAACAC
|
Abemaciclib | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
|
Verzenios 100mg tablets
0801050CLBBAAAA
|
Verzenios | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
|
Verzenios 150mg tablets
0801050CLBBABAB
|
Verzenios | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
|
Verzenios 50mg tablets
0801050CLBBACAC
|
Verzenios | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.